A randomized trial of aerobic exercise in chronic kidney disease: Evidence for blunted cardiopulmonary adaptations.
Danielle L Kirkman, Meghan G Ramick, Bryce J Muth and 3 others
PMID 33316435WHAT IT FOUND
Twelve weeks of supervised aerobic cycling improved peak oxygen uptake in non-dialysis CKD patients, but the gain fell below the minimal clinically important change and did not carry over to walking speed, grip strength, or daily activity.
Key findings
01Twelve weeks of supervised aerobic exercise increased peak oxygen uptake (VO2peak) from 17.89 to 19.98 ml/kg/min in the exercise group, while the control group declined from 18.29 to 17.36 ml/kg/min.
02The mean increase of 2.09 ml/kg/min fell below the minimal clinically important change of 2.8 ml/kg/min previously reported for CKD patients.
03Exercise training did not improve grip strength, gait speed, lower-body functional strength, or functional endurance, and habitual physical activity levels did not change.
STILL TO COME
How it was doneWhat they foundWhat it means for PTs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
Most participants were on beta-blockers or other antihypertensives, which blunt heart rate and autonomic responses, making the null findings on autonomic function hard to interpret. Randomisation was not stratified by race, so the exercise group had more African Americans than the control group (p = 0.02). The physical function battery (2-min walk, 4-m gait speed, sit-to-stand) may not be sensitive enough to detect change in this population; the authors note the 2-min walk has not been validated as a VO2peak predictor in CKD. Single-centre, 12-week duration; longer interventions (around a year) in other CKD studies have produced larger VO2peak gains. No data on systemic outcomes such as inflammation or the renin-angiotensin-aldosterone system.
Declared interests
No conflicts of interest declared.
The easy way to misread this
Do not read the significant VO2peak increase as a clinically meaningful benefit for your patient. The mean gain of 2.09 ml/kg/min fell below the 2.8 ml/kg/min minimal clinically important change for CKD patients, and none of the physical function measures improved. A patient who completes 12 weeks of supervised cycling may not notice a difference in how far they can walk or how quickly they can stand up.
Summarised by AI from the full paper, without a clinician reviewing it. Check it against the source before it changes what you do. Read it on PubMed →